![David Lambeth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Lambeth
Corporate Officer/Principal chez
Emory University School of Medicine
Profil
David Lambeth is the founder of Calliditas Therapeutics Suisse SA, which was founded in 2006.
He is currently a Professor at Emory University School of Medicine, where he has been working since 1980.
Dr. Lambeth received a doctorate degree from Duke University.
Postes actifs de David Lambeth
| Sociétés | Poste | Début |
|---|---|---|
Emory University School of Medicine
 Emory University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1980 |
Anciens postes connus de David Lambeth
| Sociétés | Poste | Fin |
|---|---|---|
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Fondateur | - |
Formation de David Lambeth
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
25
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emory University School of Medicine
Emory University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
